What is the role of dipyridamole in long-term secondary prevention after an ischemic stroke or transient ischemic attack?
Sudlow
Cathie
C
Division of Clinical Neurosciences, University of Edinburgh, Western General Hospital, Edinburgh, Scotland.
D001241:Aspirin / Q000494:pharmacology / Q000627:therapeutic use; D004176:Dipyridamole / Q000009:adverse effects / Q000627:therapeutic use*; D019317:Evidence-Based Medicine; D006801:Humans; D002546:Ischemic Attack, Transient / Q000517:prevention & control*; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D020521:Stroke / Q000517:prevention & control*
D010975:Platelet Aggregation Inhibitors; D004176:Dipyridamole; D001241:Aspirin